NAV: 29 Nov 2024 | ₹22.67 |
Min. SIP amount | Not Supported |
Rating | NA |
Fund size | ₹851.53Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 37.5% | 18.3% | 13.9% |
Category average | NA | 40.9% | 19.2% | NA |
Rank with in category | NA | 13 | 6 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 25.08% |
Cipla Ltd. | Healthcare | Equity | 10.71% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 9.76% |
Divi's Laboratories Ltd. | Healthcare | Equity | 9.39% |
Lupin Ltd. | Healthcare | Equity | 6.62% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 4.90% |
Alkem Laboratories Ltd. | Healthcare | Equity | 3.79% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.71% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 3.20% |
Mankind Pharma Ltd. | Healthcare | Equity | 3.16% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 3.14% |
Ipca Laboratories Ltd. | Healthcare | Equity | 2.71% |
Laurus Labs Ltd. | Healthcare | Equity | 2.43% |
Abbott India Ltd. | Healthcare | Equity | 1.90% |
Biocon Ltd. | Healthcare | Equity | 1.78% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 1.76% |
Gland Pharma Ltd. | Healthcare | Equity | 1.65% |
Ajanta Pharma Ltd. | Healthcare | Equity | 1.62% |
Natco Pharma Ltd. | Healthcare | Equity | 1.60% |
Granules India Ltd. | Healthcare | Equity | 1.03% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Min. for 1st investment | Not Supported |
Min. for 2nd investment onwards | Not Supported |
Min. for SIP | Not Supported |